Cargando…
A randomized crossover study comparing trehalose/hyaluronate eyedrops and standard treatment: patient satisfaction in the treatment of dry eye syndrome
Dry eye is a common disorder in routine ophthalmological practice, and a better understanding of the complex pathophysiology is leading to improved treatment. Thealoz Duo(®) is a novel artificial tear preparation containing two active ingredients: Trehalose, a naturally occurring disaccharide with a...
Autores principales: | Pinto-Bonilla, Juan Carlos, del Olmo-Jimeno, Alberto, Llovet-Osuna, Fernando, Hernández-Galilea, Emiliano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403513/ https://www.ncbi.nlm.nih.gov/pubmed/25926736 http://dx.doi.org/10.2147/TCRM.S77091 |
Ejemplares similares
-
Trehalose/hyaluronate eyedrop effects on ocular surface inflammatory markers and mucin expression in dry eye patients
por: Fariselli, Chiara, et al.
Publicado: (2018) -
Tear Film Stabilization and Symptom Improvement in Dry Eye Disease: The Role of Hyaluronic Acid and Trehalose Eyedrops versus Carmellose Sodium
por: Sánchez-González, José-María, et al.
Publicado: (2023) -
Comparison of Trehalose/Hyaluronic Acid (HA) vs. 0.001% Hydrocortisone/HA Eyedrops on Signs and Inflammatory Markers in a Desiccating Model of Dry Eye Disease (DED)
por: Astolfi, Gloria, et al.
Publicado: (2022) -
Allogeneic Umbilical Cord Plasma Eyedrops for the Treatment of Recalcitrant Dry Eye Disease Patients
por: Wong, Joy, et al.
Publicado: (2023) -
Clinical Efficacy of an Eyedrop Containing Hyaluronic Acid and Ginkgo Biloba in the Management of Dry Eye Disease Induced by Cataract Surgery
por: Fogagnolo, Paolo, et al.
Publicado: (2022)